Washing with alkaline solutions in protein A purification improves physicochemical properties of monoclonal antibodies.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 01 2021
Historique:
received: 27 10 2020
accepted: 06 01 2021
entrez: 20 1 2021
pubmed: 21 1 2021
medline: 7 10 2021
Statut: epublish

Résumé

Protein A affinity chromatography has been widely used for both laboratory scale purification and commercial manufacturing of monoclonal antibodies and Fc-fusion proteins. Protein A purification is specific and efficient. However, there still remain several issues to be addressed, such as incomplete clearance of impurities including host cell proteins, DNA, aggregates, etc. In addition, the effects of wash buffers in protein A purification on the physicochemical characteristics of antibodies have yet to be fully understood. Here we found a new purification protocol for monoclonal antibodies that can improve physicochemical properties of monoclonal antibodies simply by inserting an additional wash step with a basic buffer after the capture step to the conventional protein A purification. The effects of the alkaline wash on monoclonal antibodies were investigated in terms of physicochemical characteristics, yields, and impurity clearance. The simple insertion of an alkaline wash step resulted in protection of antibodies from irreversible aggregation, reduction in free thiols and impurities, an improvement in colloidal and storage stability, and enhanced yields. This new procedure is widely applicable to protein A affinity chromatography of monoclonal antibodies.

Identifiants

pubmed: 33469121
doi: 10.1038/s41598-021-81366-6
pii: 10.1038/s41598-021-81366-6
pmc: PMC7815873
doi:

Substances chimiques

Alkalies 0
Antibodies, Monoclonal 0
Solutions 0
Staphylococcal Protein A 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1827

Commentaires et corrections

Type : ErratumIn

Références

Biotechnol Prog. 2008 Sep-Oct;24(5):1115-21
pubmed: 19194921
FEBS Lett. 1972 Nov 15;28(1):73-6
pubmed: 4630462
J Biol Chem. 2012 Jul 20;287(30):25266-79
pubmed: 22584577
Antioxid Redox Signal. 2013 May 1;18(13):1623-41
pubmed: 23075118
J Immunol. 1966 Dec;97(6):822-7
pubmed: 4163007
J Chromatogr A. 2016 Jul 15;1455:9-19
pubmed: 27283099
Methods Mol Biol. 1984;1:13-20
pubmed: 20512670
Anal Bioanal Chem. 2002 Jul;373(4-5):266-76
pubmed: 12110978
J Immunotoxicol. 2014 Apr-Jun;11(2):99-109
pubmed: 23919460
J Pharm Sci. 2015 Jun;104(6):1885-1898
pubmed: 25821140
J Pharm Sci. 2009 Apr;98(4):1201-5
pubmed: 18704929
Front Immunol. 2016 Feb 02;7:21
pubmed: 26870037
Pharm Res. 1990 Jul;7(7):703-11
pubmed: 2395797
J Pharm Sci. 2011 Jul;100(7):2551-62
pubmed: 21294130
J Chromatogr A. 2015 Oct 9;1415:83-90
pubmed: 26346187
Biophys J. 2010 Oct 20;99(8):2657-65
pubmed: 20959107
J Chromatogr A. 2016 Feb 12;1433:98-105
pubmed: 26805601
J Chromatogr B Biomed Sci Appl. 2001 Mar 10;752(2):233-45
pubmed: 11270864
MAbs. 2010 Sep-Oct;2(5):480-99
pubmed: 20647768
J Chromatogr A. 2015 May 22;1395:136-42
pubmed: 25882588
Nat Rev Immunol. 2007 Sep;7(9):715-25
pubmed: 17703228
J Chromatogr A. 2007 Nov 9;1171(1-2):22-8
pubmed: 17920607
Biophys J. 2000 Jan;78(1):394-404
pubmed: 10620303
Trends Biotechnol. 2013 Nov;31(11):612-20
pubmed: 23932102
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Mar 15;848(1):28-39
pubmed: 17046339
MAbs. 2020 Jan-Dec;12(1):1703531
pubmed: 31847708
Anal Chem. 2010 Jun 15;82(12):5219-26
pubmed: 20491447
MAbs. 2016 Aug-Sep;8(6):1088-97
pubmed: 27210456
Anal Chem. 2013 Jan 15;85(2):715-36
pubmed: 23134362
Protein Expr Purif. 2004 Aug;36(2):244-8
pubmed: 15249046
J Pharm Sci. 2014 Apr;103(4):1032-42
pubmed: 24549831
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Mar 15;848(1):40-7
pubmed: 17030158
Biotechnol Bioeng. 2011 Jul;108(7):1494-508
pubmed: 21480193
Pharm Res. 2012 Feb;29(2):397-410
pubmed: 21853361
Biophys J. 2012 Jul 3;103(1):69-78
pubmed: 22828333
Protein Sci. 2010 Sep;19(9):1601-15
pubmed: 20556807
J Immunol Methods. 1997 Feb 14;201(1):25-34
pubmed: 9032407

Auteurs

Yuichi Imura (Y)

Sohyaku. Innovative Research Department, Mitsubishi Tanabe Pharma Corporation, Yokohama, Japan. yimura@trlusa.com.
Development Department, Tanabe Research Laboratories U.S.A. Inc., San Diego, USA. yimura@trlusa.com.

Toshiaki Tagawa (T)

Sohyaku. Innovative Research Department, Mitsubishi Tanabe Pharma Corporation, Yokohama, Japan.

Yuya Miyamoto (Y)

Sohyaku. Innovative Research Department, Mitsubishi Tanabe Pharma Corporation, Fujisawa, Japan.

Satoshi Nonoyama (S)

Sohyaku. Innovative Research Department, Mitsubishi Tanabe Pharma Corporation, Yokohama, Japan.

Hiroshi Sumichika (H)

Sohyaku. Innovative Research Department, Mitsubishi Tanabe Pharma Corporation, Yokohama, Japan.

Yasuhiro Fujino (Y)

Sohyaku. Innovative Research Department, Mitsubishi Tanabe Pharma Corporation, Yokohama, Japan.
Research Department, Tanabe Research Laboratories U.S.A. Inc., San Diego, USA.

Masaya Yamanouchi (M)

Sohyaku. Innovative Research Department, Mitsubishi Tanabe Pharma Corporation, Yokohama, Japan.

Hideo Miki (H)

Sohyaku. Innovative Research Department, Mitsubishi Tanabe Pharma Corporation, Fujisawa, Japan.

Articles similaires

Humans Amyotrophic Lateral Sclerosis Male Middle Aged Female

Measurement of α-synuclein as protein cargo in plasma extracellular vesicles.

Tal Gilboa, Dmitry Ter-Ovanesyan, Shih-Chin Wang et al.
1.00
alpha-Synuclein Extracellular Vesicles Humans Phosphorylation Parkinson Disease
Humans Epitopes Antibodies, Monoclonal Immunoglobulin Fab Fragments Cryoelectron Microscopy

Classifications MeSH